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Clinical Observations 
Effects of Liandou Qingmai Recipe (䖲䈚⏙㛝ᮍ) on Endothelin-1, Nitric 
Oxide, Interleukin-6 and Interleukin-10 Levels in Patients with  
Coronary Heart Disease 
ZHU Hong-junᴅ㑶֞ 1,2, LU Shu䰚Ჭ 1, SU Wei㢣ӳ 1, GONG Shao-yu啮ᇥᛮ 1, ZHANG Zhi-binᓴᖫ᭠ 3,  
LI Pingᴢ㧡 3, WEI Hui-yuan儣᜻⏞ 1, YANG Qing-youᴼᑚ᳝ 1, TANG Hong૤㱍 1, XIA Cheng-xia໣៤䳲 1,  
and ZHU Mingᴅᯢ 1
Objective: To observe effects of Liandou Qingmai Recipe (䖲䈚⏙㛝ᮍ) on endothelin-1 (ET-1), nitric oxide (NO), 
interleukin-6 (IL-6) and IL-10 levels in patients with coronary heart disease.  
Methods: Total 101 cases with coronary heart disease were randomly divided into a treatment group (n=45) treated 
by Liandou Qingmai Recipe and a standard treatment group (control group, n=56), with a normal group of 16 health 
persons set up. Changes of ET-1, NO, IL-6 and IL-10 levels were measured before treatment and after treatment for 
two weeks. And the data were analyzed by SPSS 16.0 statistic software. 
Results: Before treatment, the levels of ET-1, IL-6 and IL-10 levels were significantly higher and NO was 
significantly lower in the patients with coronary heart disease than those in the normal group (90.7±12.7 ng/L vs 
41.8±13.5 ng/L, 9.17±0.18 ng/L vs 1.10±0.08 ng/L, 1.94±0.26 ng/L vs 1.09±0.06 ng/L, and 92.2±17.7 ȝmol/L vs 
124.5±27.2 ȝmol/L; all P<0.05), with no significant differences in the levels of ET-1, NO, IL-6 and IL-10 between 
the treatment group and the control group (P>0.05); After treatment, ET-1 and IL-6 significantly decreased in the 
treatment group and the control group, and NO increased in the treatment group; And IL-6 level was significantly 
lower and NO level was higher in the treatment group than those in the control group (4.48±1.22 ng/L vs 5.13±1.85 
ng/L, 117.4±22.3 μmol/L vs 92.4±17.1 μmol/L; both P<0.05); There was a positive correlation between IL-6 and 
IL-10, and a negative correlation between NO and IL-10 (r=0.142, r=-0.152; both P<0.05).  
Conclusion: Liandou Qingmai Recipe can decline IL-6, IL-10 and ET-1 levels, and raise NO level in patients with 
coronary heart disease on the basis of standard treatment, so as to inhibit endothelial inflammatory response, 
improve vascular endothelial function, with stronger anti-AS action; And vascular endothelial lesion is related with 
inflammatory response.  
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Atherosclerosis (AS) is pathological basis of coronary 
heart disease and its basic pathogenesis is deficiency in 
origin and excess in superficiality, and phlegm and blood 
stasis. The authors hold that AS is caused by pathogenic 
heat, phlegm and blood stasis jointly transferring into 
turbid due to insufficiency of kidney, and “heat, turbid 
and deficiency of kidney” are the most important 
pathogenesis.1,2 Therefore, “clearing away heat, 
removing the turbid and tonifying the kidney” is basic 
principle for treatment of AS.3 On these grounds, 
Liandou Qingmai Recipe (䖲䈚⏙㛝ᮍ ) the authors 
developed has better clinical effects in prevention and 
treatment of AS and relative diseases. A study has 
confirmed that this recipe can further decrease brachial- 
ankle pulse wave velocity and increase ankle-brachial 
index in atherosclerosis patients on the basis of standard 
treatment. 4 It has a better effect of improving arterial 
rigidity degree, and it is verified that the recipe can 
decrease low density lipoprotein-cholesterol level and 
atherosclerosis-inducing index in plasma in ather- 
osclerosis patients, giving full play to anti-AS; At the 
same time, it can decrease ultra-sensitive C-response 
protein and peripheral white blood cells, with a better 
anti-inflammation action. Thus, it is inferred that the 
mechanism of Liandou Qingmai Recipe for treatment of 
AS is possibly involved in anti-inflammation and 
improvement of endothelial dysfunction.1So, in the study, 
effects of Liandou Qingmai Recipe on endothelin-1 
(ET-1), nitric oxide (NO), interleukin-6 (IL-6), and IL-10 
in atherosclerosis patients were investigated. A report is 
following.  
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METHODS 
Diagnostic Criteria of Coronary Heart Disease 
Diagnosis of coronary heart disease referred to The 
Nomenclature and Diagnostic Criteria of Ischemic Heart 
Diseases issued by WHO.5 
General Data 
Altogether, 101 patients of coronary heart disease and 16 
health volunteers were included in this study. The 
patients all were inpatients in the Heart Internal Medicine 
Department, Wuxi Hospital Affiliated to Nanjing 
University of Traditional Chinese Medicine from June 
2007 to December 2009. They were randomly divided 
into Liandou Qingmai Recipe treatment group (treatment 
group and standard treatment group (control group) 
according to random number table. In the treatment 
group of 45 cases, 20 cases were male and 25 cases were 
female; Aged 51-87 years, averaging (71.2±8.4) years; 
The course of disease was 1 h to 40 years with a mean of 
(median 5.27 (1.00–12.02)) years. In the control group of 
56 cases, 24 cases were male and 32 cases were female; 
Aged 54-86 years with a mean of (70.4±8.9) years; The 
course of disease was 1 h to 40 years averaging (median 
5.14 (1.00–11.97)) years. There were no statistically 
significant differences between the two groups in age, 
sex and course of disease. Members of the normal 
control group (normal group) of 16 healthy volunteers 
were staff and workers at their posts or retirees in this 
hospital after matching age and sex.. This study through 
the hospital's ethics committee for examination and 
approval, all study subjects are informed consent and 
signed informed consent.  
Criteria of Inclusion 
Meet the diagnostic criteria of coronary heart disease and 
conform to any one item of following conditions:  
remote myocardial infarction, hemodynamically stable 
acute myocardial infarction or angina pectoris, positive 
sports plate test with clinical symptom and sign, at least 
one blood vessel or at least one part of a vessel 
narrowing over 60% found by coronary arteriography; 
and the patients voluntarily signed the a fact-known 
consent. 
Criteria of Exclusion 
The patients of insufficiency of the spleen-yang in 
traditional Chinese medicine, hemodynamically unstable 
angina pectoris and acute myocardial infarction, severe 
arrhythmia, complicated other severe heart diseases, 
severe dysfunction of liver and kidney, severe original 
diseases of lung and brain, psychosis, or refusing to sign 
a fact-known consent, were excluded. 
Treatment Methods 
The patients in the treatment group and the control group 
were treated with a standard treatment, including nitrate 
type drugs (such as Isosorbide mononitrate tablets 20 mg, 
twice each day, Isosorbide dinitrate, 5–10 mg, thrice 
daily, and nitroglycerin according to patient’s condition), 
Aspirin (100–300 mg, once each day), Statins type drugs 
for regulating lipids (such as Atovastatin calcium tablets 
10–20 mg, once each day, Fluovastatin sodium capsules 
40 mg, once each night, etc.),  Angiotensin-converting 
enzyme inhibitor (Benazepril tablets 10 mg, once each 
day,  Peduopril tablets 4 mg, once daily, etc);  For the 
patient of no contraindication, ȕ-receptor blockers, etc.  
(Metoprolol tablets 6.25 mg–100 mg, twice each day,
Bisoprolol tablets 2.5 mg–5.0 mg, once each day, etc.) 
were used for long term in whole course; There were no 
statistically significant differences between the two 
group in the drug kinds, dose and therapeutic course for 
the standard treatment. For the patients in the treatment 
group, Liandou Qingmai Recipe composed of Lianqiao 
(Fructus Forsythiae) 15 g, Huanglian (Rhizoma Coptidis) 
3 g, Yeliaodou (䞢᭭䈚) 15 g, Chishao (Radix Paeoniae) 
10 g, Laifuzi (Semen Raphani) 10 g, and so on, was 
added on the basis of standard treatment, which prepared 
by Pharmaceutics Department in the hospital and the 
herbs were purchased from Jiangzhong Pharmaceutical
Factory, 250 mL each decoction, oral administration, 
twice each day, two weeks consisted of one therapeutic 
course. 
Collection and Preservation of Samples 
Six mL blood was taken from vein of the patient within 
24 h after hospitalization on empty stomach in the 
morning. Among them, 2 mL was slowly poured into a 
tube with 30 μL 10% EDTA and mixed, and stood for 1 h 
at room temperature, and then centrifuged at 3000 r/min 
for 10 min. The supernatant was taken and poured into a 
tube, sealed and kept at -70 ć for ET-1 determination; 
Other 4 mL blood were poured into a dry tube and stood 
for 1 h at room temperature, and then centrifuged for 10 
min at 3000 r/min. A part of the supernatant was kept in a 
tube and sealed, and kept at -70 ć  for NO 
determination; And another part of the supernatant was 
used for determination of IL-6 and IL-10 determination 
immediately. 
After treatment for two weeks, collection, preservation 
and determination of the above samples were repeated. 
ET-1 and NO were determined together once each 6 
months.  
Observation Indexes and Determination Methods 
NO kit purchased from Nanjing Jiancheng Bio- 
engineering Institute was used for determination of NO 
with 751G spectrophotometer; ET-1 radioimmunoassay 
kit made by Beijing North Biotechnology Institute was 
used for automatic determination of ET-1 with GC911 
radioimmunoanalyser; IL-6 and IL-10 were determined 
with special agents by IMMULITE 1000 full-automatic 
chemiluminescence immunoanalyser (Siemens Co., 
Germany). 
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Statistical Analysis 
The data were statistically analyzed with SPSS16.0 
software packet. The measurement data were expressed 
as x fs; Two-side student-t test of two independent 
samples was used for comparison of therapeutic effects 
between groups, and two-side student-t test of paired 
samples was used for comparison of therapeutic effects 
before and after treatment in-group, significant level Į= 
0.05.
RESULTS 
Comparison of IL-6, IL-10, ET-1 and NO Levels 
before Treatment between the Coronary Heart 
Disease Group and the Normal Group
Before treatment, ET-1, IL-6, IL-10 and NO levels were 
90.7±12.7 ng/L, 9.17±0.18 ng/L, 1.94±0.26 ng/L and 
92.2±17.7 ȝmol/L in the coronary heart disease group 
(the control group plus the treatment group), and 
41.8±13.5 ng/L, 1.10±0.08 ng/L, 1.09±0.06 ng/L, and 
124.5±27.2 ȝmol/L in the normal group, respectively. 
ET-1, IL-6, IL-10 levels before treatment in the coronary 
heart disease group were significantly higher and NO 
was lower than those in the normal group (all P<0.05, 
Table 1). 
Effects of Liandou Qingmai Recipe on IL-6, IL-10, 
ET-1 and NO levels 
Before treatment, there were no significant differences in 
IL-6, IL-10, ET-1 and NO levels between the treatment 
group and the control group (P>0.05). After treatment, 
ET-1 and IL-6 levels significantly decreased (P<0.05) 
and NO and IL-10 did not significantly change in the 
control group; ET-1 and IL-6 levels decreased and NO 
increased significantly (both P<0.05), and IL-10 did not 
significantly change in the treatment group; NO level 
was significantly higher and IL-6 was significantly lower 
in the treatment group than those in the control group 
(both P<0.05); And there were no significant differences 
in ET-1 and IL-10 levels between the two groups (Table 
1). 
Correlativity between Endothelial Function and 
Inflammatory Indexes 
There was a positive correlation between IL-6 and IL-10 
(r=0.142, P=0.039) and a negative correlation between 
NO and IL-10 (r=-0.152, P=0.027). There was no 
statistically correlation between ET-1 and NO, NO and 
IL-6, ET-1 and IL-6, ET-1 and IL-10. 
Table 1. Effects of Liandou Qingmai Recipe (䖲䈚⏙㛝ᮍ) on IL-6, IL-10, ET-1 and NO levels 
Group Cases IL-6 (ng/L) IL-10 (ng/L) ET-1 (ng/L) NO (μmol/L) 
Normal group 16 1.10±0.08 1.09±0.06 41.8±13.5 124.5±27.2 
9.22±2.05 1.95±0.32 89.9±13.1 91.9±18.2 
Control group1 
  Before treatment  
After treatment 
56 
5.13±1.85* 1.65±0.18 64.6±9.8* 92.4±17.1 
9.11±1.36 1.93±0.19 91.6±11.9 92.5±17.7 
Treatment group2 
Before treatment 
After treatment 
45 
  4.48±1.22*Ÿ 1.82±0.19 59.5±8.7*   117.4±22.3*Ÿ
Notes: Compared with the data before treatment, *P<0.05; Compared with the control group, ƷP<0.05. 
1. Control (standard treatment group); 2. Treatment (Liandou Qingmai Recipe treatment group) 
DISCUSSION 
Atherosclerosis is physiopathologic basis of coronary 
heart disease, and it has endothelial dysfunction at 
various stages from its formation and development to 
occurrence of clinical symptoms and signs. Vascular 
active substances secreted from vascular endothelium 
play an important metabolic and regulatory role. Among 
them, endothelins (ETs) are the most important 
vasoconstrictive substance, and it plays an important role 
in the course of atherosclerosis. It can induce contraction 
of various vessels with the most sensitive for coronary 
artery. ET has 3 kinds of isomer and ET-1 has the 
strongest vasoconstrictive action. In vitro experiment 
indicates that the vasoconstrictive action of ET-1 is 10 
times stronger than angiotensin II, and it is the strongest 
vasoconstrictive factor known at present.6 While, NO 
was a gas molecule with varied biological activities, and 
with very short half-life period, being unstable, and it has 
been proved that it is diastolic factor derived from 
endothelium with actions of strongly dilating blood 
vessels, inhibiting aggregation and activation of blood 
platelet, inhibiting infiltration and absorption of 
neutrophilic granulocytes and mononuclear leukocytes 
for vascular wall, inhibiting proliferation of vascular 
smooth muscle and anti-thrombosis. In atherosclerosis, 
lesion of endothelial function induces decrease of NO 
synthesis and increase of NO decomposition, leading to 
decrease of NO level, disturbance of fibrinolytic function 
and reduction of anti-thrombosis, further deteriorating 
atherosclerosis.7 This study confirmed that in the patients 
with coronary heart disease ET-1 level was significantly 
higher and NO significantly was lower than those in the 
healthy persons, which are uniform with literature and 
further verify that disturbance of endothelial function is 
an important pathological basis of AS. 
Liandou Qingmai Recipe is composed mainly of 
Lianqiao (Fructus Forsythiae), Huanglian (Rhizoma 
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Coptidis), Yeliaodou ( 䞢 ᭭ 䈚 ), Chishao (Radix 
Paeoniae), Laifuzi (Semen Raphani), and so on. Modern 
pharmacological studies find that these Chinese 
medicines have varied pharmacologic functions, such as 
antisepsis, anti-inflammation, decreasing blood pressure, 
reducing blood lipids, and antioxidation, and so on. 
Lizuka T, et al. found that forsythiaside extracted and 
separated from fruits of Forsythia suspensa had 
antagonistic action on calcium ion.8 These 
pharmacological mechanisms are beneficial for 
improving arterial endothelial function. This study 
further verified that on the basis of standard treatment, 
Liandou Qingmai Recipe could decrease ET-1 
concentration, alleviate the unfavorable vasoconstrictive 
action of ET-1 on coronary heart disease; increase NO 
level, strengthening the actions of dilating blood vessels, 
inhibiting aggregation and activation of blood platelets, 
inhibiting infiltration and absorption of neutrophilic 
granulocytes and mononuclear leukocytes for vascular 
wall, inhibiting proliferation of vascular smooth muscle 
cells and anti-thrombosis in the patient with coronary 
heart disease, so as to improve endothelial function. 
Inflammatory response is an important mechanism for
occurrence and development of AS and coronary heart 
disease. Among them, IL-6 is one of strong inflammatory 
factors inducing inflammatory response, and it makes 
generation of vascular endothelial active oxygen cluster 
increase, oxygen free radicals evoking oxidative stress, 
inducing dysfunction of vascular endothelium, 
accelerating atherosclerosis.9 IL-6 expression is found in 
both the part of plaque of coronary atherosclerosis and 
the arterial wall injured by atherosclerosis, and the 
expression amount is 10–40 times higher than that in the 
normal tissue.10 Plasma IL-6 concentration in the patient 
of unstable angina pectoris is significantly higher than 
that in the patients of stable angina pectoris or the normal 
control group.11 IL-10 is an main anti-inflammatory 
cytokine, and it can inhibit activities of mononuclear 
cells and macrophages, etc., and down-regulate the 
stimulating action of chemotactic factor and 
inflammatory factor on proliferation of smooth muscular 
cells, and directly inhibit expression of adhesive 
molecules, prevent  ischemia / reperfusion lesion of 
myocardium, protect myocardium. IL-10 also can reduce 
metalloprotease activity in the plaque.12 Smith, et al. 
found that serum IL-10 concentration in the patient of 
unstable angina pectoris was significantly lower than that 
in the patient of stable angina pectoris.13 It is indicated 
that IL-10 is inversely proportional to AS plaque 
unstable degrees. Therefore, IL-10 plays possibly an 
important role in inhibiting occurrence and development 
of coronary heart disease. In this study, it also was 
proved that IL-6 level in the patient of coronary heart 
disease was significantly higher than that in the patients 
of the normal group, indicating that endothelial function 
lesion is related with inflammatory response. 
Antibacterial action of Huanglian (Rhizoma Coptidis) 
and Lianqiao (Fructus Forsythiaein), etc. in the Liandou 
Qingmai Recipe is well known clinically. A study proved 
that extract of Huanglian (Rhizoma Coptidis) can reduce 
breaking times of aortic atherosclerotic plaque in 
ApoE-gene knockout mice, helping stabilize vulnerable 
atherosclerotic plaque.14 While this present study proved 
that on the basis of standard treatment, Liandou Qingmai 
Recipe could decrease IL-6 and IL-10 concentrations, 
inhibit injuring action of IL-6 on vascular endothelium in 
the patient of coronary heart disease, so as to improve 
vascular endothelial function. IL-6 and ET-1 were 
decreased and NO was increased in both the treatment 
group and the control group, but after combination of 
Liandou Qingmai Recipe with standard treatment, the 
effects of decreasing ET-1 and increasing NO were 
significantly strengthened. Therefore, Liandou Qingmai 
Recipe can further strengthen the effects of inhibiting 
vascular endothelial inflammatory response, inhibiting 
release of vascular endothelins, promoting release of NO, 
so as to improve vascular endothelial function and 
arthrosclerosis. 
Also, a study found that compared with the patients of no 
occurrence of new coronary arterial event, the ratio of  
IL-6 to IL10 significantly increased in the patients of 
occurrence of new coronary arterial event.15 It is inferred 
that IL-10 and IL-6 ought to show antagonistic relation. 
But, in both the control group and the treatment group, 
both IL-6 and IL-10 decreased, so they could not play 
anti-inflammatory role in the two groups through 
increasing IL-10 concentration. Further analysis found 
that IL-6 and IL-10 were positive correlation (r=0.142). 
Thus, the authors hold that IL-10 possibly does not have 
actively inhibiting action on AS , while at the unstable 
stress state of AS plaque, IL-10 passively increases the 
inhibiting effect on inflammatory response, so as to 
inhibit advance of AS.   
In addition, in the patient of coronary heart disease 
plasma ET level increased, NO level decreased, with a 
negative correlation between them. Zellers, et al.16 found 
that in normal physiologic condition, ET can stimulate 
release of endothelial NO, so as to decrease itself 
vasoconstrictive action; ET and NO restrict, antagonize 
and coordinate each other, being a dynamic balance 
relation. In this study, there was no a statistically 
significant negative correlation between ET-1 and NO. 
Theoretically, the stronger the inflammatory response, 
the more severe the endothelial lesion, thus inflammatory 
response indexes and endothelial function indexes should 
have certain correlativity. This hypothesis was partially 
confirmed by this study: NO and IL-10 showed a 
negative correlation (r=0.152). This conforms with that 
the physiopathologic mechanisms, i.e., when 
inflammatory response is severe and IL-10 increases, 
endothelial function will be injured and NO release will 
reduce; when inflammatory response is inhibited and 
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IL-10 decreases, endothelial function will improve and 
release of NO will increase. 
In brief, on the basis of standard treatment, Liandou 
Qingmai Recipe can decrease IL-6, IL-10 and ET-1 
levels and increase NO level in the patient with coronary 
heart disease, so as to inhibit the endothelial 
inflammatory response, improve vascular endothelial 
function, with stronger anti-AS action. And the data in 
the study proves partially correlativity between 
inflammatory indexes and endothelial function indexes, 
and inflammatory response is one of important 
mechanisms of endothelial function lesion. 
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